Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 4, 2012, Pages 639-642

  Jobu, Kohei ^a,b   Sun, Changhai ^b,c   Yoshioka, Saburo ^b   Yokota, Junko ^b   Onogawa, Masahide ^b   Kawada, Chiaki ^d   Inoue, Keiji ^d   Shuin, Taro ^d   Sendo, Toshiaki ^e   Miyamura, Mitsuhiko ^a,b  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL HOSPITAL   (Japan)

^c JIAMUSI UNIVERSITY   (China)

^d KOCHI MEDICAL SCHOOL   (Japan)

^e OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bladder cancer; GC MS; Metabolomics; Urine odor

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; HUMAN; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REPRODUCIBILITY; SENSITIVITY ANALYSIS; URINE CYTOLOGY; URINE ODOR;

CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METABOLOMICS; NEOPLASM STAGING; ODORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84859448583     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.639     Document Type: Article

References (15)

1. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T; Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn. J. Clin. Oncol., 41, 139-147 (2011).
2. Lee R, Droller MJ. The natural history of bladder cancer. Implications for therapy. Urol. Clin. North Am., 27, 1-13, vii (2000).
3. Willis CM, Church SM, Guest CM, Cook WA, McCarthy N, Bransbury AJ, Church MR, Church JC. Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ, 329, 712-717 (2004).
4. McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K, Janecki T. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr. Cancer Ther., 5, 30-39 (2006).
5. Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, McVay WP. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet, 353, 1930-1933 (1999).
6. Di Natale C, Macagnano A, Martinelli E, Paolesse R, D'Arcangelo G, Roscioni C, Finazzi-Agrò A, D'Amico A. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens. Bioelectron., 18, 1209-1218 (2003).
7. Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, Gunawardena R, Kwon CS, Rahbari-Oskoui F, Wong C. Volatile markers of breast cancer in the breath. Breast J., 9, 184-191 (2003).
8. Spanel P, Smith D, Holland TA, Al Singary W, Elder JB. Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry. Rapid Commun. Mass Spectrom., 13, 1354-1359 (1999).
9. Sun C, Teng Y, Li G, Yoshioka S, Yokota J, Miyamura M, Fang H, Zhang Y. Metabonomics study of the protective effects of Lonicera japonica extract on acute liver injury in dimethylnitrosamine treated rats. J. Pharm. Biomed. Anal., 53, 98-102 (2010).
10. Shirasu M, Nagai S, Hayashi R, Ochiai A, Touhara K. Dimethyl trisulfide as a characteristic odor associated with fungating cancer wounds. Biosci. Biotechnol. Biochem., 73, 2117-2120 (2009).
11. Liddell K. Smell as a diagnostic marker. Postgrad. Med. J., 52, 136-138 (1976).
12. Dankert J, Holloway Y, Bouma J, van der Werf J, Wolthers BG. Metronidazole in smelly gynaecological tumours. Lancet, 2, 1295 (1981).
13. Shirasu M, Touhara K. The scent of disease: volatile organic compounds of the human body related to disease and disorder. J. Biochem., 150, 257-266 (2011).
14. van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur. Urol., 47, 736-748 (2005).
15. Badalament RA, Hermansen DK, Kimmel M, Gay H, Herr HW, Fair WR, Whitmore WF Jr, Melamed MR. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer, 60, 1423-1427 (1987).